Opaleye Management Reports Acquisition of $136,177.7221 in Grace Therapeutics Common Shares
Opaleye Management, a 10% owner of Grace Therapeutics, purchased 71,065 common shares. Purchases comprised 11,233 shares at $1.9349, 23,485 at $1.9453 and 36,347 at $1.8917. Indirect holdings through Opaleye, L.P. rose to 2,944,354 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using gene